Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

NJEDA: Drug Discovery Companies Quixgen and API Pharma Tech Cite Resources and Networking in Move to CCIT

12/2/2016

0 Comments

 
North Brunswick, NJ — Citing a wide array of resources and networking opportunities available to tenants at the New Jersey Economic Development Authority’s (EDA) Commercialization Center for Innovative Technologies (CCIT), entrepreneurs with ties to the Garden State’s technology community this month signed leases for lab space at the State’s leading life sciences incubator.
 
These early-stage drug discovery companies, Quixgen and API Pharma Tech, join nearly two dozen other life sciences businesses that currently call CCIT home.
 
“CCIT has welcomed over 40 emerging life sciences companies since 2010,” EDA Chief Executive Officer Melissa Orsen said. “CCIT provides the tools, support and connections that growing companies need to thrive in the Garden State, and we are pleased to welcome Quixgen and API Pharma Tech.”
 
Strategically located in the heart of the State’s research corridor between Rutgers and Princeton universities, CCIT offers the most wet labs of any incubator in New Jersey.  The incubator includes both small and large labs, as well as offices. 
​CCIT also offers discounted first-year rent for university spinouts. Additionally, CCIT provides tenant companies with educational programs and a host of supporting resources, including help to identify funding sources and providing access to small business development resources, networking opportunities and administrative support.

Quixgen founders Yusheng Xiong and Hong-Ping Guan spent over two decades at New Jersey-based pharmaceutical giant Merck before launching their company. 

They leased an 800-square-foot lab at CCIT, where Quixgen will focus on finding a niche in the drug discovery/infectious diseases market. When @NJEDATech spoke with Xiong about his arrival at CCIT, he spoke highly about the infrastructure of the lab and was already impressed with the atmosphere of the tenants and the opportunities he will have to engage with founders of other tenant companies.

Christopher Newton, founder of API Pharma Tech, moved to New Jersey from India in 2003 and became a partner and the chief scientific operator at Navinta LLC, a pharmaceutical company based in Ewing. 

In 2011, Newton founded Dr Newtons Pharma Solutions, an independent pharmaceutical consulting company based in Plainsboro, before establishing API Pharma Tech earlier this year. 

API Pharma Tech is a research-based pharmaceutical company that aims to help clients reduce research and development costs and deliver medicine to treat unmet needs. 

The company will develop and deliver products that are expected to meet the needs of people suffering from iron-dependent Anemia, chronic kidney disease, Wilson’s disease, cystine urea kidney stones, and rheumatoid arthritis. 
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
222 West State Street
Suite 302
Trenton, NJ 08608
732-729-9619